Paper
Organic & Biomolecular Chemistry
one (155 mg, 0.75 mmol) and isolated as a light yellow solid 4,6-Diphenyl-2,3′-bipyridine (4m)
(63 mg, 54% yield) OR 4i was prepared from acetophenone
Following the general procedure, 4m was prepared from aceto-
(45 mg, 0.375 mmol) and 3-phenyl-1-(thiophen-2-yl)prop-2-yn-
1-one (159 mg, 0.75 mmol) and isolated as a light yellow solid
(70 mg, 60% yield), mp 105–106 °C (lit.28 112–114 °C), Rf =
0.66 (hexane-diethyl ether, 3/1, v/v). 1H NMR (400.1 MHz,
CDCl3): δ = 8.20 (d, J = 7.1 Hz, 2H), 7.82 (s, 1H), 7.80 (s, 1H),
7.75–7.74 (m, 3H), 7.56–7.44 (m, 7H), 7.17–7.15 (m, 1H). 13C
{1H} NMR (100.6 MHz, CDCl3): δ = 157.5, 152.9, 150.3, 145.6,
139.2, 139.0, 129.3, 129.3, 129.2, 128.9, 128.1, 127.8, 127.3,
127.2, 124.8, 116.9, 115.5. HRMS (ESI-TOF) calcd for
[C21H15NS + H]+ 314.1003, found 314.1002.
phenone (45 mg, 0.375 mmol) and 3-phenyl-1-(pyridin-3-yl)
prop-2-yn-1-one (155 mg, 0.75 mmol), isolated as a white solid
(79 mg, 68% yield), mp 153–155 °C (lit.31 161 °C), Rf = 0.60
1
(diethyl ether). H NMR (400.1 MHz, CDCl3): δ = 9.40 (s, 1H),
8.69 (d, J = 3.7 Hz, 1H), 8.51 (d, J = 7.9 Hz, 1H), 8.20 (d, J = 7.2
Hz, 2H), 7.93 (s, 1H), 7.88 (s, 1H), 7.74 (d, J = 6.9 Hz, 2H),
7.56–7.42 (m, 7H). 13C{1H} NMR (100.6 MHz, CDCl3): δ =
158.0, 155.0, 150.6, 150.1, 148.6, 139.2, 138.7, 135.1, 134.6,
129.4, 129.3, 128.9, 127.2, 127.2, 123.6, 117.8, 117.1. HRMS
(ESI-TOF) calcd for [C22H16N2 + H]+ 309.1392, found 309.1390.
4,6-Diphenyl-2,2′-bipyridine (4j)
2,6-Diphenyl-4-(p-tolyl)pyridine (4n)
Following the general procedure, 4j was prepared from 2-acetyl-
pyridine (303 mg, 2.5 mmol), 1,3-diphenylprop-2-yn-1-one
(1030 mg, 5.0 mmol), potassium tert-butoxide (560 mg,
2.5 mmol) and ammonium acetate (963 mg, 12.5 mmol) in
DMSO (10 mL, 0.25 M) and isolated as a white solid (732 mg,
95% yield), mp 156–158 °C (lit.30 157–158 °C), Rf = 0.24
Following the general procedure, 4n was prepared from aceto-
phenone (45 mg, 0.375 mmol) and 1-phenyl-3-(p-tolyl)prop-2-
yn-1-one (165 mg, 0.75 mmol), isolated as a light yellow solid
(95 mg, 79% yield), mp 117–118 °C (lit.13 118–120 °C), Rf =
0.71 (hexane-diethyl ether, 3/1, v/v). 1H NMR (400.1 MHz,
CDCl3): δ = 8.27 (d, J = 7.5 Hz, 4H), 7.92 (s, 2H), 7.69 (d, J = 7.7
Hz, 2H), 7.59–7.56 (m, 4H), 7.52–7.48 (m, 2H), 7.37 (d, J = 7.7
Hz, 2H), 2.48 (s, 3H). 13C{1H} NMR (100.6 MHz, CDCl3): δ =
157.5, 150.1, 139.8, 139.1, 136.2, 129.9, 129.1, 128.8, 127.2,
127.1, 117.0, 21.3. HRMS (ESI-TOF) calcd for [C24H19N + H]+
322.1596, found 322.1593.
1
(hexane-diethyl ether, 3/1, v/v). H NMR (400.1 MHz, CDCl3): δ
= 8.74–8.70 (m, 2H), 8.68 (s, 1H), 8.23 (d, J = 7.3 Hz, 2H), 8.00
(s, 1H), 7.89–7.83 (m, 3H), 7.57–7.51 (m, 4H), 7.49–7.46 (m,
2H), 7.35–7.33 (m, 1H). 13C{1H} NMR (100.6 MHz, CDCl3): δ =
157.3, 156.5, 156.4, 150.4, 149.2, 139.6, 138.9, 137.0, 129.2,
129.1, 129.1, 128.9, 127.4, 127.2, 123.9, 121.6, 118.6, 117.7.
HRMS (ESI-TOF) calcd for [C22H16N2 + H]+ 309.1392, found
309.1393.
4-(3-Fluorophenyl)-2,6-diphenylpyridine (4o)
Following the general procedure, 4o was prepared from aceto-
phenone (45 mg, 0.375 mmol) and 3-(3-fluorophenyl)-1-phe-
nylprop-2-yn-1-one (168 mg, 0.75 mmol), isolated as a light
yellow solid (98 mg, 80% yield), mp 128–130 °C (lit.13
2-Ferrocenyl-4,6-diphenylpyridine (4k)
Following the general procedure, 4k was prepared from acetyl-
ferrocene (86 mg, 0.375 mmol) and 1,3-diphenylprop-2-yn-1-
one (155 mg, 0.75 mmol), isolated as an orange oil (80 mg,
1
138–139 °C), Rf = 0.65 (hexane-diethyl ether, 3/1, v/v). H NMR
(400.1 MHz, CDCl3): δ = 8.22 (d, J = 7.4 Hz, 4H), 7.87 (s, 2H),
7.56–7.45 (m, 9H), 7.20–7.17 (m, 1H). 13C{1H} NMR
(100.6 MHz, CDCl3): δ = 163.4 (d, J = 246.9 Hz), 157.8, 149.0 (d,
J = 2.0 Hz), 141.5 (d, J = 7.8 Hz), 139.5, 130.8 (d, J = 8.3 Hz),
129.3, 128.9, 127.3, 123.0 (d, J = 2.8 Hz), 117.0, 116.0 (d, J =
21.1 Hz), 114.3 (d, J = 22.4 Hz). HRMS (ESI-TOF) calcd for
[C23H16FN + H]+ 326.1345, found 326.1343.
1
51% yield), Rf = 0.66 (hexane-diethyl ether, 3/1, v/v). H NMR
(400.1 MHz, CDCl3): δ = 8.22 (d, J = 7.1 Hz, 2H), 7.77–7.75 (m,
3H), 7.58–7.45 (m, 7H), 5.12–5.11 (m, 2H), 4.46–4.45 (m, 2H),
4.12 (s, 5H). 13C{1H} NMR (100.6 MHz, CDCl3): δ = 160.0,
157.1, 149.3, 139.9, 139.4, 129.2, 129.0, 129.0, 128.8, 127.3,
127.2, 116.7, 115.7, 84.5, 70.0, 69.8, 67.8. HRMS (ESI-TOF)
calcd for [C27H21FeN + H]+ 416.1102, found 416.1101.
4-(3-Methoxyphenyl)-2,6-diphenylpyridine (4p)
2-(tert-Butyl)-4,6-diphenylpyridine (4l)
Following the general procedure, 4p was prepared from aceto-
Following the general procedure, 4l was prepared from 3,3-di- phenone (45 mg, 0.375 mmol) and 3-(3-methoxyphenyl)-1-phe-
methylbutan-2-one (38 mg, 0.375 mmol) and 1,3-diphenyl- nylprop-2-yn-1-one (177 mg, 0.75 mmol), isolated as a light
prop-2-yn-1-one (155 mg, 0.75 mmol), isolated as a light pink beige solid (85 mg, 67% yield), mp 122–124 °C (lit.32
1
solid (64 mg, 59% yield), mp 88–90 °C (lit.28 87–89 °C), Rf = 121–122 °C), Rf = 0.57 (hexane-diethyl ether, 3/1, v/v). H NMR
0.83 (hexane-diethyl ether, 3/1, v/v). 1H NMR (400.1 MHz, (400.1 MHz, CDCl3): δ = 8.21 (d, J = 7.4 Hz, 4H), 7.89 (s, 2H),
CDCl3): δ = 8.23 (d, J = 7.2 Hz, 2H), 7.82 (s, 1H), 7.74 (d, J = 7.1 7.54–7.51 (m, 4H), 7.47–7.44 (m, 3H), 7.34 (d, J = 7.6 Hz, 1H),
Hz, 2H), 7.57–7.44 (m, 7H), 1.56 (s, 9H). 13C{1H} NMR 7.27–7.26 (m, 1H), 7.02 (d, J = 8.1 Hz, 1H), 3.91 (s, 3H). 13C{1H}
(100.6 MHz, CDCl3): δ = 169.7, 156.2, 149.6, 140.1, 139.9, NMR (100.6 MHz, CDCl3): δ = 160.3, 157.6, 150.1, 140.6, 139.7,
129.1, 128.9, 128.7, 128.7, 127.4, 127.1, 115.9, 115.6, 38.0, 30.5. 130.3, 129.1, 128.8, 127.2, 119.7, 117.2, 114.3, 113.1, 55.5.
HRMS (ESI-TOF) calcd for [C21H21N + H]+ 288.1752, found HRMS (ESI-TOF) calcd for [C24H19NO + H]+ 338.1545, found
288.1752.
338.1545.
2710 | Org. Biomol. Chem., 2021, 19, 2703–2715
This journal is © The Royal Society of Chemistry 2021